πŸ‡ΊπŸ‡Έ FDA
Patent

US 9079916

Heteroaryl derivatives as CFTR modulators

granted A61KA61K31/443A61K31/497

Quick answer

US patent 9079916 (Heteroaryl derivatives as CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K31/443, A61K31/497, A61K31/501, A61K31/506